Michael J Sladden (Michael Sladden, M Sladden)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 13

Top Topics

Coronary Artery Bypass

Top Venues

Journal of the European Academy of Dermatology and Venereology : JEADV

The Australasian journal of dermatology

The British journal of dermatology

This page only lists publications with an associated author ORCID identifier.

Publications

Anthony Joseph Dixon, Athanassios Kyrgidis, Michael J Sladden, Alexander Nirenberg, Howard K Steinman, Harvey Ronald Smith, Christopher B Zachary, Stuart Anderson, Ulrike Leiter, Caterina Longo, Zoi Apalla
BAUSSS biomarker further validated as a key risk staging tool for patients with primary melanoma. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Anthony Joseph Dixon, Athanassios Kyrgidis, Howard K Steinman, John B Dixon, Michael J Sladden, Claus Garbe, Aimillios Lallas, Christopher B Zachary, Ulrike Leiter, Harvey Ronald Smith, Alexander Nirenberg, Christos C Zouboulis, Caterina Longo, Giuseppe Argenziano, Zoi Apalla, Catalin Popescu, Thrasyvoulos Tzellos, Stuart Anderson, Lena Nanz, Lloyd Cleaver, J Meirion Thomas
Sentinel lymph node biopsy is unreliable in predicting melanoma mortality for both younger and older patients. Journal of the European Academy of Dermatology and Venereology : JEADV 38 (4) (2024)
Anthony Joseph Dixon, Athanassios Kyrgidis, Howard K Steinman, John B Dixon, Michael J Sladden, Claus Garbe, Aimillios Lallas, Christopher B Zachary, Ulrike Leiter, Harvey Ronald Smith, Alexander Nirenberg, Christos C Zouboulis, Caterina Longo, Giuseppe Argenziano, Zoi Apalla, Catalin Popescu, Thrasyvoulos Tzellos, Stuart Anderson, Lena Nanz, Lloyd Cleaver, J Meirion Thomas
Sentinel lymph node biopsy is unreliable in predicting melanoma mortality for both younger and older patients. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Anthony Joseph Dixon, Athanassios Kyrgidis, Michael J Sladden, Alexander Nirenberg, Howard K Steinman, Harvey Ronald Smith, Christopher B Zachary, Stuart Anderson, Ulrike Leiter, Caterina Longo, Zoi Apalla
BAUSSS biomarker further validated as a key risk staging tool for patients with primary melanoma. Journal of the European Academy of Dermatology and Venereology : JEADV 38 (9) (2024)
Anthony Joseph Dixon, Athanassios Kyrgidis, Howard K Steinman, John B Dixon, Michael J Sladden, Claus Garbe, Aimillios Lallas, Christopher B Zachary, Ulrike Leiter, Harvey Ronald Smith, Alexander Nirenberg, Christos C Zouboulis, Caterina Longo, Giuseppe Argenziano, Zoi Apalla, Catalin Popescu, Thrasyvoulos Tzellos, Stuart Anderson, Lena Nanz, Lloyd Cleaver, J Meirion Thomas
Sentinel lymph node biopsy is unreliable in predicting melanoma mortality for both younger and older patients. Journal of the European Academy of Dermatology and Venereology : JEADV 38 (4) (2024)
Anthony Joseph Dixon, Howard K Steinman, Alexander Nirenberg, Christos C Zouboulis, Michael J Sladden, Catalin Popescu, Stuart Anderson, Caterina Longo, J Meirion Thomas
BAUSSS biomarker improves melanoma survival risk assessment. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Athanassios Kyrgidis, Anthony Joseph Dixon, Michael J Sladden, Howard K Steinman, Christos C Zouboulis, Aimillios Lallas, Samantha Schneider, Harvey Ronald Smith, Alexander Nirenberg, Caterina Longo, Giuseppe Argenziano, Catalin Popescu, Thrasyvoulos Tzellos, Stuart Anderson, J Meirion Thomas
Sentinel lymph node biopsy may no longer be a critical component of melanoma management. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Anthony Joseph Dixon, Athanassios Kyrgidis, Christopher Zachary, John Dixon, Catalin Popescu, Michael J Sladden, Zoi Apalla, Stuart Anderson, Giuseppe Argenziano, Demitrios Ioannides, Alexander Nirenberg, Aimillios Lallas, Samuel Zagarella, Caterina Longo, Harvey Smith, Howard K Steinman, Thrasivoulos Tzellos, Lloyd Cleaver, Ken Leahey, Christos C Zouboulis, J Meirion Thomas
Multicentre Selective Lymphadenectomy Trial 1: key primary data remain unavailable. The British journal of dermatology 187 (6) (2022)
Alexis Arasu, Niyati Sharma, Anousha Yazdabadi, Michael J Sladden
Dual biologic therapy with Omalizumab and Dupilumab for refractory atopic disease. The Australasian journal of dermatology (2021)
Michael J Sladden, Samuel S Zagarella, C Popescu, M Bigby
The sentinel node biopsy has not come of age. The British journal of dermatology 182 (2) (2019)
Saxon D Smith, Christopher Baker, Kurt Gebauer, Diana Rubel, Brad Frankum, H Peter Soyer, Warren Weightman, Michael J Sladden, Morton Rawlin, Alexander P Headley, Colin Somerville, Julie Beuth, Nick Logan, Erin Mewton, Peter Foley
Atopic dermatitis in adults: An Australian management consensus. The Australasian journal of dermatology 61 (1) (2019)
Michael J Sladden, Samuel S Zagarella, Catalin Popescu, Michael Bigby
When is a sentinel node biopsy indicated for patients with primary melanoma? Comment on the 'Australian guidelines for the management of cutaneous melanoma'. The Australasian journal of dermatology 59 (2) (2018)
Samuel S Zagarella, Michael J Sladden, Catalin M Popescu, Michael E Bigby
'Role of sentinel lymph node biopsy as a staging procedure in patients with melanoma: A critical appraisal' by Omgo E Nieweg, Alan Cooper and John F Thompson. The Australasian journal of dermatology 59 (2) (2018)